---
title: "Orexin agonist ALKS 7290 shows ADHD symptom improvement in early Phase 1 trial"
id: "stat-news-0-stat-alkermes-orexin-agonist-shows-potential-to-treat-adhd-in-early-stage-trial"
canonical_url: "https://medichelpline.com/clinical-feed/stat-news-0-stat-alkermes-orexin-agonist-shows-potential-to-treat-adhd-in-early-stage-trial"
content_type: "clinical_feed_article"
specialty: "Neurology"
source_name: "STAT News"
source_url: "https://www.statnews.com/2026/09/21/alkermes-orexin-agonist-adhd-study/?utm_campaign=rss"
published_at: "2026-09-21T11:00:00.000Z"
evidence_level: "Verified Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Orexin agonist ALKS 7290 shows ADHD symptom improvement in early Phase 1 trial
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/stat-news-0-stat-alkermes-orexin-agonist-shows-potential-to-treat-adhd-in-early-stage-trial
- **Specialty:** [Neurology](https://medichelpline.com/clinical-feed/neurology.md)
- **Primary Source:** STAT News
- **Source URL:** [Original Journal Publication](https://www.statnews.com/2026/09/21/alkermes-orexin-agonist-adhd-study/?utm_campaign=rss)
- **Published At:** 2026-09-21T11:00:00.000Z
- **Evidence Rating:** Verified Feed
## Executive GIST (TL;DR)
- Alkermes tested an **orexin agonist**, ALKS 7290, in a randomized Phase 1 study and reported the drug was **well tolerated** and showed a signal of efficacy for ADHD. - Participants entered the study with a median score of 39 on the **Adult ADHD Investigator Symptom Rating Scale**, consistent with moderate to severe symptoms. - After two weeks, participants receiving a high dose of 50 mg of ALKS 7290 had a 19-point reduction on that scale, which the company described as a shift to mild symptoms. - The report positions this as the first demonstration that the orexin agonist class, previously noted for treating rare sleep disorders, may have benefit in **ADHD**. - The source notes the trial was randomized and Phase 1, but the STAT article is behind a subscriber paywall and the public summary did not report certain details such as exact sample size, comparator (placebo or active), statistical analyses, or longer-term follow-up. - The company’s announcement emphasizes tolerability and an early efficacy signal; full data and peer-reviewed results were not provided in the public summary cited. - This early-stage finding suggests a potential new therapeutic avenue for ADHD, but additional, larger studies will be needed to confirm safety, efficacy, dosing, and durability of effect.
## Clinical Analysis & Structured Key Points
[Skip to Main Content](https://www.statnews.com/2026/09/21/alkermes-orexin-agonist-adhd-study/?utm_campaign=rss#wrapper) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo-white.svg) ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/09/21/alkermes-orexin-agonist-adhd-study/?utm_campaign=rss) [Cancer](https://www.statnews.com/topic/cancer/) [research](https://www.statnews.com/topic/research/) [patients](https://www.statnews.com/topic/patients/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) My Account * [Settings Complete your personal information for a more tailored experience ](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing](https://www.statnews.com/my-account/billing/) * [Log In](https://www.statnews.com/login/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) Reporting from the frontiers of health and medicine ](https://www.statnews.com/) * [Newsletters](https://www.statnews.com/signup/) * [Log In](https://www.statnews.com/login/) * [My Account](https://www.statnews.com/my-account/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Public Health](https://www.statnews.com/category/health/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Policy](https://www.statnews.com/category/politics/) * [Science](https://www.statnews.com/category/in-the-lab/) * [First Opinion](https://www.statnews.com/category/first-opinion/) * [STAT+](https://www.statnews.com/topic/stat-plus/) * [STAT Events](https://www.statnews.com/events/) [ ![STAT](https://www.statnews.com/wp-content/themes/stat/images/stat-logo.svg) ](https://www.statnews.com/) Search * [Log In](https://www.statnews.com/login/) * [Subscribe Now](https://www.statnews.com/stat-plus/) * [My Account](https://www.statnews.com/my-account/) My Account * [Settings](https://www.statnews.com/my-account/) * [Saved Stories](https://www.statnews.com/my-account/saved/) * [Billing History](https://www.statnews.com/my-account/billing/) [Home](https://www.statnews.com/) News * [Latest](https://www.statnews.com/latest/) * [Series & Investigations](https://www.statnews.com/stat-series-and-investigations-award-winning-journalism/) * Business * [Biotech](https://www.statnews.com/category/biotech/) * [Pharma](https://www.statnews.com/category/pharma/) * [Health Tech](https://www.statnews.com/category/health-tech/) * [Health Insurance](https://www.statnews.com/category/insurance/) * [Hospitals](https://www.statnews.com/category/hospitals/) * [Medical Devices](https://www.statnews.com/topic/medical-devices/) * Washington * [Policy](https://www.statnews.com/category/politics/) * [FDA](https://www.statnews.com/topic/fda/) * [NIH](https://www.statnews.com/topic/nih/) * Science * [CRISPR](https://www.statnews.com/topic/crispr/) * [Gene Therapy](https://www.statnews.com/topic/gene-therapy/) * [Neuroscience](https://www.statnews.com/topic/neuroscience/) * Public Health * [Addiction](https://www.statnews.com/topic/addiction/) * [Covid-19](https://www.statnews.com/topic/coronavirus/) * [Abortion](https://www.statnews.com/topic/abortion/) * [Health Disparities](https://www.statnews.com/topic/health-disparities/) * [Infectious Disease](https://www.statnews.com/topic/infectious-disease/) * [Mental Health](https://www.statnews.com/topic/mental-health/) * Disease * [Cancer](https://www.statnews.com/topic/cancer/) * [Cardiovascular Disease](https://www.statnews.com/topic/cardiovascular-disease/) * [Chronic Disease](https://www.statnews.com/topic/chronic-disease/) * [Diabetes](https://www.statnews.com/topic/diabetes/) * [Alzheimer's](https://www.statnews.com/topic/alzheimers/) * [Obesity](https://www.statnews.com/topic/obesity/) * Features * [Health Care Costs](https://www.statnews.com/health-insurance-costs-out-of-pocket-out-of-reach-series/) * [The Deadliest Drug](https://www.statnews.com/alcohol-epidemic-hiding-plain-sight-deadliest-drug-series/) * [Science, Shattered](https://www.statnews.com/american-science-shattered/) [Newsletters](https://www.statnews.com/signup/) [Opinion](https://www.statnews.com/category/first-opinion/) Columns * [Adam Feuerstein](https://www.statnews.com/category/adams-take/) * [Matthew Herper](https://www.statnews.com/category/matts-take/) * [Ed Silverman](https://www.statnews.com/category/pharmalot-view/) [Reports](https://reports.statnews.com/) [E-books](https://www.statnews.com/ebooks/) [Podcasts](https://www.statnews.com/podcasts/) [Tools & Trackers](https://www.statnews.com/trackers/) * [CRISPR Tracker](https://www.statnews.com/feature/crispr/tracker/) * [Breakthrough Device Tracker](https://www.statnews.com/feature/stat-plus/breakthrough-device-designation-fda-tracker/) * [Generative AI Tracker](https://www.statnews.com/feature/stat-plus/generative-ai-health-hospitals-tracker/) * [Obesity Drug Tracker](https://www.statnews.com/2023/09/12/new-weight-loss-drug-tracker-novo-nordisk-eli-lilly/) [Events](https://www.statnews.com/events/) * [Upcoming Events](https://www.statnews.com/events#upcoming-events) * [Summits](https://www.statnews.com/stat-summits/) [Community](https://www.statnews.com/community/) * [STAT Wunderkinds 2026](https://www.statnews.com/wunderkinds-nominate/) [Video](https://youtube.com/@Statnews) [Advertise](https://www.statnews.com/advertise/) * [STAT Brand Studio](https://sbs.statnews.com/) What's the word? Test your knowledge with our new weekday mini crossword [ Start solving ](https://www.statnews.com/stat-mini-crossword/) [STAT Plus](https://www.statnews.com/stat-plus/)[Biotech](https://www.statnews.com/category/biotech/) # Alkermes’ orexin agonist shows potential to treat ADHD in early-stage trial ## New class of treatments has drawn interest in a wide range of conditions * [Manage alerts for this article](https://www.statnews.com/my-account/edit/#emails) * [Save this story for later](https://www.statnews.com/my-account/saved/) * [Share this article](https://www.statnews.com/2026/09/21/alkermes-orexin-agonist-adhd-study/?utm_campaign=rss) ![Alkermes headquarters](https://www.statnews.com/wp-content/uploads/2026/09/alkermes-900-winter-st-645x645.jpg) Alkermes ![](https://www.statnews.com/wp-content/uploads/2022/12/elaine-chen-avatar-round-80x80.png) By [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) Sept. 21, 2026 Chen, a national biotech reporter, is the co-author of [The Readout](https://www.statnews.com/signup/readout/), a newsletter about the business, science, and politics of biotech. ![](https://www.statnews.com/wp-content/uploads/2022/12/elaine-chen-avatar-round-80x80.png) [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) 1. [](https://www.linkedin.com/in/elaineywchen/ "Linkedin") 2. [](https://x.com/elaineywchen "X") elaine.chen@statnews.com Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes [The Readout newsletter](https://www.statnews.com/signup/readout/), and co-hosts STAT’s weekly biotech podcast, [The Readout Loud](https://www.statnews.com/category/readout-loud/). You can reach Elaine on Signal at elaineywchen.70. Drugs called orexin agonists have been [hailed for their ability to treat rare sleep disorders](https://www.statnews.com/2025/07/22/narcolepsy-treatment-orexin-trials-future-of-wakefulness-drugs/), but with new data, Alkermes is showing for the first time that the new class of therapies may benefit people with ADHD. In a randomized Phase 1 study, the company’s new drug, called ALKS 7290, was well tolerated and showed a signal of efficacy, Alkermes said Monday. Advertisement Participants in the study started with a median score of 39 on a diagnostic known as the Adult ADHD Investigator Symptom Rating Scale, indicating that they had moderate to severe symptoms. After two weeks, those taking a high dose of 50 milligrams of ALKS 7290 experienced a 19-point reduction on the scale, indicating that their symptoms had become mild. [![STAT+](https://www.statnews.com/wp-content/themes/stat/images/stat-plus-logo.svg)](https://www.statnews.com/stat-plus/) To read the rest of this story subscribe to STAT+. [Subscribe](https://www.statnews.com/stat-plus/) [Log In](https://www.statnews.com/login/) [biotechnology](https://www.statnews.com/topic/biotechnology/), [drug development](https://www.statnews.com/topic/drug-development/), [Pharmaceuticals](https://www.statnews.com/topic/pharmaceuticals/), [STAT+](https://www.statnews.com/topic/stat-plus/) [Submit a correction request](https://www.statnews.com/contact/?how_can_we_help_=Editorial%20Correction%20Request)[Reprints](https://www.parsintl.com/publications/stat/) 1. ![](https://www.statnews.com/wp-content/uploads/2022/12/elaine-chen-avatar-round-80x80.png) [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) 1. [](https://x.com/elaineywchen "X") 2. [](https://bsky.app/profile/elaineywchen.bsky.social "Bluesky") 3. 4. [](https://www.linkedin.com/in/elaineywchen/ "Linkedin") National Biotech Reporter 1. [](https://x.com/elaineywchen "X") 2. [](https://bsky.app/profile/elaineywchen.bsky.social "Bluesky") 3. 4. [](https://www.linkedin.com/in/elaineywchen/ "Linkedin") Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes [The Readout newsletter](https://www.statnews.com/signup/readout/), and co-hosts STAT’s weekly biotech podcast, [The Readout Loud](https://www.statnews.com/category/readout-loud/). You can reach Elaine on Signal at elaineywchen.70. ![](https://www.statnews.com/wp-content/themes/stat/images/article-new/envelope-open.svg) ![](https://www.statnews.com/wp-content/uploads/2023/06/The-Readout-Logo-Black-640x99.png) ### Newsletter Your morning rundown of the science, politics, and money driving biotech today Please enter a valid email address. Sign Up Your data will be processed in accordance with our [Privacy Policy](https://www.statnews.com/privacy/) and [Terms of Service](https://www.statnews.com/terms-conditions/). You may opt out of receiving STAT communications at any time. Advertisement Most Popular 1. ![](https://www.statnews.com/wp-content/uploads/2025/09/20190371158_c548350aea_o-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [The NIH budget should be $100 billion per year](https://www.statnews.com/2026/09/21/nih-budget-double-100-billion-reed-jobs/) 2. ![](https://www.statnews.com/wp-content/uploads/2025/07/mike-doustdar-3-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [With new strategy, Novo outlines plans for obesity, direct-to-consumer work](https://www.statnews.com/2026/09/21/novo-nordisk-capital-markets-day-obesity-strategy/) 3. ![](https://www.statnews.com/wp-content/uploads/2026/08/radiopharma-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Radiopharma companies merge after one receives surprise FDA rejection](https://www.statnews.com/2026/09/20/radiopharma-companies-itm-telix-merger/) 4. ![](https://www.statnews.com/wp-content/uploads/2022/04/AP22039367701680-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A geriatrician explains why AI for older adults deserves careful scrutiny](https://www.statnews.com/2026/09/18/geriatrician-explains-why-ai-for-older-adults-deserves-careful-scrutiny/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/09/kratom-80x80.jpg) [Addiction clinics see rising cases of kratom and 7-OH withdrawal](https://www.statnews.com/2026/09/21/kratom-withdrawal-addiction-centers-report-surge/) #### [ Reports ](https://reports.statnews.com/) [ ![](https://www.statnews.com/wp-content/uploads/2026/08/2026_CancerReport_ReportCover-328x424.jpg) Explore Cancer’s transformational moments: KRAS, CAR-T, immunotherapy, and more ](https://reports.statnews.com/products/cancer-transformational-moments-advances-in-kras-car-t-immunotherapy) Advertisement #### [Events](https://www.statnews.com/events/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/924_Samsung_VirtualEvent_Wordpress_FeaturedImage-80x80.jpg) Biosimilars: Have We Reached an Inflection Point? Virtual Sep 24 ](https://www.statnews.com/event/biosimilars-what-is-next-virtual-event-sept-2026/) [ ![](https://www.statnews.com/wp-content/uploads/2026/01/Flagship2026_Wordpress_CalendarImageRegGoLive-1-80x80.jpg) 2026 STAT Summit Boston, MA Oct 14 ](https://www.statnews.com/event/2026-stat-summit/) [ ![](https://www.statnews.com/wp-content/uploads/2026/07/2026_DD_OfficeHours_VirtualEvent_Wordpress_CalendarImage-80x80.jpg) Office Hours with Isabella Cueto and Lev Facher Virtual Jul 29 ](https://www.statnews.com/event/deadliest-drug-series-office-hours-ama-july-2026/) Most Read in [STAT+](https://www.statnews.com/stat-plus/) 1. ![](https://www.statnews.com/wp-content/uploads/2025/12/AdobeStock_288008063-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Vera kidney drug Trutakna shows strong final results in Phase 3 trial](https://www.statnews.com/2026/09/15/vera-kidney-drug-trutakna-shows-strong-phase-3-results-igan/) 2. ![](https://www.statnews.com/wp-content/uploads/2026/09/Eliza-treated-with-Gene-therapy-2016-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease](https://www.statnews.com/2026/09/17/sanfilippo-syndrome-treatment-ultragenyx-approval/) 3. ![](https://www.statnews.com/wp-content/uploads/2022/06/AdamsTake_Illustration_MollyFerguson_061322-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A Sellas immunotherapy study, long delayed, will end in failure](https://www.statnews.com/2026/09/17/sellas-immunotherapy-study-acute-myeloid-leukemia/) 4. ![](https://www.statnews.com/wp-content/uploads/2025/12/AdobeStock_1649079417-80x80.jpeg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [A biotech hedge fund births a new immunology company ](https://www.statnews.com/2026/09/17/biotech-hedge-fund-startup-north-immunology/) 5. ![](https://www.statnews.com/wp-content/uploads/2026/09/GettyImages-2292889136-80x80.jpg) ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [Medicare to expand its pilot that pays for technology to manage chronic diseases](https://www.statnews.com/2026/09/15/medicare-access-chronic-care-management-tech-pilot-expanding/) #### Recommended ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Pharma Pharma September 20, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Radiopharma companies merge after one receives surprise FDA rejection ](https://www.statnews.com/2026/09/20/radiopharma-companies-itm-telix-merger/) By [Allison DeAngelis](https://www.statnews.com/staff/allison-deangelis/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout September 18, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Roche expands its Boston footprint with new research center ](https://www.statnews.com/2026/09/18/biotech-news-roche-expands-it-boston-footprint-with-research-center/) By [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/), [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/), and [Margaret Manto](https://www.statnews.com/staff/margaret-manto/) Advertisement ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Biotech Biotech September 17, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease ](https://www.statnews.com/2026/09/17/sanfilippo-syndrome-treatment-ultragenyx-approval/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) The Readout The Readout September 17, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: New startup to test psychedelic-like drug against Parkinson’s symptom ](https://www.statnews.com/2026/09/17/biotech-news-ariadne-testing-psychedelic-like-drug-parkinsons-apathy/) By [Meghana Keshavan](https://www.statnews.com/staff/meghana-keshavan/) and [Elaine Chen](https://www.statnews.com/staff/elaine-chen/) ![](https://www.statnews.com/wp-content/plugins/stat-lazy-load/images/328x185-00000000.png) Adam's Biotech Scorecard Adam's Biotech Scorecard September 17, 2026 ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: A Sellas immunotherapy study, long delayed, will end in failure ](https://www.statnews.com/2026/09/17/sellas-immunotherapy-study-acute-myeloid-leukemia/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) #### Subscriber Picks 1. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: Medicare's AI prior authorization pilot was rushed and full of problems, new documents reveal ](https://www.statnews.com/2026/09/15/medicare-wiser-ai-prior-authorization-pilot-rushed-launch-delayed-care/) By [Brittany Trang](https://www.statnews.com/staff/brittany-trang/) 2. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: A Sellas immunotherapy study, long delayed, will end in failure ](https://www.statnews.com/2026/09/17/sellas-immunotherapy-study-acute-myeloid-leukemia/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) 3. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: FDA approves a new gene therapy for Sanfilippo syndrome, an ultra-rare disease ](https://www.statnews.com/2026/09/17/sanfilippo-syndrome-treatment-ultragenyx-approval/) By [Jason Mast](https://www.statnews.com/staff/jason-mast/) 4. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: A geriatrician explains why AI for older adults deserves careful scrutiny ](https://www.statnews.com/2026/09/18/geriatrician-explains-why-ai-for-older-adults-deserves-careful-scrutiny/) By [Katie Palmer](https://www.statnews.com/staff/katie-palmer/) 5. ### ![](https://www.statnews.com/wp-content/themes/stat/images/home/statplus.svg) [ STAT Plus: A biotech hedge fund births a new immunology company ](https://www.statnews.com/2026/09/17/biotech-hedge-fund-startup-north-immunology/) By [Adam Feuerstein](https://www.statnews.com/staff/adam-feuerstein/) Share options * [ X ](https://twitter.com/intent/tweet?url=https://www.statnews.com/2026/09/21/alkermes-orexin-agonist-adhd-study/&via=statnews&text=Alkermes%E2%80%99%20orexin%20agoni
## Related Clinical Research

- [Startup to test psychedelic-like drug for Parkinson’s apathy — STAT+ report](https://medichelpline.com/clinical-feed/stat-news-0-stat-new-startup-to-test-psychedelic-like-drug-against-parkinson-s-symptom.md)
- [Reduced added sugar in the first 1,000 days tied to lower Alzheimer’s and dementia risk](https://medichelpline.com/clinical-feed/medical-news-today-0-cutting-added-sugar-before-age-2-linked-to-lower-dementia-depression-risk-in.md)
- [Time-restricted eating tied to improved cognitive performance in small pilot study](https://medichelpline.com/clinical-feed/medical-news-today-0-time-restricted-eating-linked-to-better-cognitive-function-in-pilot-study.md)
- [FDA approves Fayuvi gene therapy for Sanfilippo syndrome type A — first approved treatment](https://medichelpline.com/clinical-feed/stat-news-2-stat-fda-approves-a-new-gene-therapy-for-sanfilippo-syndrome-an-ultra-rare.md)

## Navigation
- [← Back to Neurology Feed](https://medichelpline.com/clinical-feed/neurology.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.